Tyler Stone Wealth Management Buys 652 Shares of VanEck Biotech ETF (NASDAQ:BBH)

Tyler Stone Wealth Management increased its stake in shares of VanEck Biotech ETF (NASDAQ:BBH) by 79.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,472 shares of the company’s stock after buying an additional 652 shares during the quarter. Tyler Stone Wealth Management owned 0.06% of VanEck Biotech ETF worth $261,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. International Assets Investment Management LLC lifted its holdings in shares of VanEck Biotech ETF by 10,376,390.9% during the third quarter. International Assets Investment Management LLC now owns 1,141,414 shares of the company’s stock valued at $202,475,000 after acquiring an additional 1,141,403 shares during the period. Northwestern Mutual Wealth Management Co. lifted its holdings in VanEck Biotech ETF by 5.8% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 24,324 shares of the company’s stock valued at $4,096,000 after purchasing an additional 1,334 shares during the last quarter. Atlas Capital Advisors LLC acquired a new position in VanEck Biotech ETF in the second quarter valued at about $960,000. Truist Financial Corp grew its stake in VanEck Biotech ETF by 3.8% during the second quarter. Truist Financial Corp now owns 2,703 shares of the company’s stock worth $455,000 after buying an additional 100 shares during the last quarter. Finally, Hyman Charles D bought a new stake in VanEck Biotech ETF during the second quarter worth about $202,000. Institutional investors and hedge funds own 32.05% of the company’s stock.

VanEck Biotech ETF Trading Down 1.1 %

NASDAQ:BBH opened at $172.90 on Tuesday. VanEck Biotech ETF has a 1 year low of $146.10 and a 1 year high of $183.64. The firm has a 50 day moving average of $175.93 and a 200-day moving average of $173.01.

About VanEck Biotech ETF

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.